WebSite > Wuhan Jingkangen Biomedical Technology Co., Ltd
Wuhan Jingkangen Biomedical Technology Co., Ltd
- Company Name Wuhan Jingkangen Biomedical Technology Co., Ltd
- Tel 00-13720134139 +86 -0-15871494362
- Email orders@jknbiochem.com
- WebSite www.jknbiochem.com
- CB Index 58
- -
Wuhan Jingkangen Biomedical Technology Co., Ltd Product List
- Product Name Solanezumab
- MF
- CAS 955085-14-0
- Product Name Daratumumab
- MF
- CAS 945721-28-8
- Product Name Vedolizumab
- MF
- CAS 943609-66-3
- Product Name Rilotumumab
- MF
- CAS 872514-65-3
- Product Name Rovelizumab
- MF
- CAS 339086-79-2
- Product Name Bectumomab
- MF
- CAS 158318-63-9
- Product Name Nerelimomab
- MF
- CAS 162774-06-3
- Product Name Oxelumab
- MF
- CAS 1186098-83-8
- Product Name Samalizumab
- MF
- CAS 1073059-33-2
- Product Name Roledumab
- MF
- CAS 1174008-79-7
- Product Name Olokizumab
- MF
- CAS 1007223-17-7
- Product Name Carlumab
- MF
- CAS 915404-94-3
- Product Name Enokizumab
- MF
- CAS 909875-08-7
- Product Name Fulranumab
- MF
- CAS 902141-80-4
- Product Name Etrolizumab
- MF
- CAS 1044758-60-2
- Product Name Enavatuzumab
- MF
- CAS 1062149-33-0
- Product Name Atinumab
- MF
- CAS 1226761-65-4
- Product Name Namilumab
- MF
- CAS 1206681-39-1
- Product Name Icrucumab
- MF
- CAS 1024603-92-6
- Product Name Mogamulizumab
- MF
- CAS 1159266-37-1
- Product Name Ponezumab
- MF
- CAS 1178862-65-1
- Product Name Onartuzumab
- MF
- CAS 1133766-06-9
- Product Name Vepalimomab
- MF
- CAS 195158-85-1
- Product Name Zolimomabaritox
- MF
- CAS 141483-72-9
- Product Name Minretumomab
- MF
- CAS 195189-17-4
- Product Name Nacolomab Tafenatox
- MF
- CAS 150631-27-9
- Product Name Maslimomab
- MF
- CAS 127757-92-0
- Product Name Fezakinumab
- MF
- CAS 1007106-86-6
- Product Name Intetumumab
- MF
- CAS 725735-28-4
- Product Name Sifalimumab
- MF
- CAS 1006877-41-3
- Product Name Lebrikizumab
- MF
- CAS 953400-68-5
- Product Name Rontalizumab
- MF
- CAS 948570-30-7
- Product Name Secukinumab
- MF
- CAS 1229022-83-6
- Product Name Girentuximab
- MF
- CAS 916138-87-9
- Product Name Suvizumab
- MF
- CAS 914257-21-9
- Product Name Teprotumumab
- MF
- CAS 1036734-93-6
- Product Name Mavrilimumab
- MF
- CAS 1085337-57-0
- Product Name Benralizumab
- MF
- CAS 1044511-01-4
- Product Name Dalotuzumab
- MF
- CAS 1005389-60-5
- Product Name Glembatumumab
- MF
- CAS 1020264-78-1
- Product Name Olaratumab
- MF
- CAS 1024603-93-7
- Product Name Itolizumab
- MF
- CAS 1116433-11-4
- Product Name Foralumab
- MF
- CAS 946415-64-1
- Product Name Ensituximab
- MF
- CAS 1092658-06-4
- Product Name Drozitumab
- MF
- CAS 912628-39-8
- Product Name Caplacizumab
- MF
- CAS 915810-67-2
- Product Name Indatuximab Ravtansine
- MF
- CAS 1238517-16-2
- Product Name Bezlotoxumab
- MF
- CAS 1246264-45-8
- Product Name Alirocumab
- MF
- CAS 1245916-14-6
- Product Name Patritumab
- MF
- CAS 1262787-83-6
- Product Name Solitomab
- MF
- CAS 1005198-65-1
- Product Name Flanvotumab
- MF
- CAS 1188277-05-5
- Product Name Romosozumab
- MF
- CAS 909395-70-6
- Product Name Quilizumab
- MF
- CAS 1228538-47-3
- Product Name Actoxumab
- MF
- CAS 1245634-25-6
- Product Name Sirukumab
- MF
- CAS 1194585-53-9
- Product Name Tabalumab
- MF
- CAS 1143503-67-6
- Product Name Vatelizumab
- MF
- CAS 1238217-55-4
- Product Name Pateclizumab
- MF
- CAS 1202526-59-7
- Product Name Ozoralizumab
- MF
- CAS 1167985-17-2
- Product Name Brodalumab
- MF
- CAS 1174395-19-7
- Product Name Ficlatuzumab
- MF
- CAS 1174900-84-5
- Product Name Narnatumab
- MF
- CAS 1188275-92-4
- Product Name Crenezumab
- MF
- CAS 1095207-05-8
- Product Name Blosozumab
- MF
- CAS 1132758-87-2
- Product Name Urelumab
- MF
- CAS 934823-49-1
- Product Name Vesencumab
- MF
- CAS 1205533-60-3
- Product Name Ublituximab
- MF
- CAS 1174014-05-1
- Product Name Tregalizumab
- MF
- CAS 1207446-68-1
- Product Name Radretumab
- MF
- CAS 1253180-81-2
- Product Name Tildrakizumab
- MF
- CAS 1326244-10-3
- Product Name Nesvacumab
- MF
- CAS 1296818-77-3
- Product Name Dusigitumab
- MF
- CAS 1204390-13-5
- Product Name Seribantumab
- MF
- CAS 1334296-12-6
- Product Name Bimagrumab
- MF
- CAS 1356922-05-8
- Product Name Pinatuzumab Vedotin
- MF
- CAS 1313706-14-7
- Product Name Ozanezumab
- MF
- CAS 1310680-64-8
- Product Name Pidilizumab
- MF
- CAS 1036730-42-3
- Product Name Pritoxaximab
- MF
- CAS 1351470-16-0
- Product Name Setoxaximab
- MF
- CAS 1351470-17-1
- Product Name Concizumab
- MF
- CAS 1312299-39-0
- Product Name Evolocumab
- MF
- CAS 1256937-27-5
- Product Name Modotuximab
- MF
- CAS 1310460-86-6
- Product Name Vorsetuzumab
- MF
- CAS 1165740-62-4
- Product Name Futuximab
- MF
- CAS 1310460-85-5
- Product Name Imgatuzumab
- MF
- CAS 959963-46-3
- Product Name Lirilumab
- MF
- CAS 1000676-41-4
- Product Name Lampalizumab
- MF
- CAS 1278466-20-8
- Product Name Ligelizumab
- MF
- CAS 1322627-61-1
- Product Name Orticumab
- MF
- CAS 1314241-10-5
- Product Name Parsatuzumab
- MF
- CAS 1312797-14-0
- Product Name Ocaratuzumab
- MF
- CAS 1169956-08-4
- Product Name Perakizumab
- MF
- CAS 1331830-76-2
- Product Name Placulumab
- MF
- CAS 945781-29-3
- Product Name Simtuzumab
- MF
- CAS 1318075-13-6
- Product Name Enoticumab
- MF
- CAS 1192578-27-0
- Product Name Duligotuzumab
- MF
- CAS 1314238-96-4
- Product Name Clazakizumab
- MF
- CAS 1236278-28-6
- Product Name Fasinumab
- MF
- CAS 1190239-42-9
- Product Name Lodelcizumab
- MF
- CAS 1355338-54-3